Shu-Yue Ji

SUMOylation and palmitoylation in metastatic prostate cancer: A compartment-based framework for nuclear and membrane adaptation.

Metastatic prostate cancer remains lethal despite treatment intensification, in part because tumor cells can adopt rapid and reversible states that are not fully explained by genomic alterations. Post-translational modifications provide a dynamic regulatory layer by changing protein activity, localization, stability, a...